Geographical variation in anti-diabetic prescribing in Ireland in 2013 and 2014: a cross-sectional analysis
ConclusionsThere is substantial geographical variation in the prescribing of new T2DM medicines, particularly GLP-1 agonists. The prescribing variation which was identified may not only represent differences in the application of clinical guidelines, but also variation in professional opinion or patient preference.
Source: Family Practice - Category: Primary Care Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Type 2 | Endocrinology | Family Practices | Fortamet | Ireland Health | Metformin